4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-(2-aminoethyl)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol

ID: ALA1095624

PubChem CID: 11959310

Max Phase: Preclinical

Molecular Formula: C17H21N7O2

Molecular Weight: 355.40

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CCN)cc21

Standard InChI:  InChI=1S/C17H21N7O2/c1-4-24-12-9-10(6-8-18)20-11(5-7-17(2,3)25)13(12)21-16(24)14-15(19)23-26-22-14/h9,25H,4,6,8,18H2,1-3H3,(H2,19,23)

Standard InChI Key:  GXNBGLREIKBKRC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   11.2491   -1.3686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7546   -0.7122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9741   -0.9825    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9915   -1.8085    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.7827   -2.0459    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9951    0.0769    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.0726   -1.3527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0497   -2.1777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7662   -1.7644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7633   -0.9338    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0479   -0.5247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5531   -2.0143    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3349   -1.7648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3376   -0.9426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5557   -0.6874    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.5298   -2.8390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8039   -3.2312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0428    0.3003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0375    1.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0333    1.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7457    2.3703    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3168    2.3631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0292    2.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4813   -2.1757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1951   -1.7621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9102   -2.1735    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  6  1  0
  2  3  2  0
  1  7  1  0
 12 13  1  0
 14 15  1  0
 15  7  2  0
  7 12  1  0
  1  2  1  0
 12 16  1  0
 13  8  1  0
 16 17  1  0
  3  4  1  0
 11 18  1  0
  8  9  2  0
 18 19  3  0
  4  5  1  0
 19 20  1  0
  9 10  1  0
 20 21  1  0
  5  1  2  0
 20 22  1  0
 10 11  2  0
 20 23  1  0
 11 14  1  0
  9 24  1  0
 13 14  2  0
 24 25  1  0
 25 26  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA1095624

   4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-(2-aminoethyl)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 355.40

Molecular Weight (Monoisotopic): 355.1757

AlogP: 0.71

#Rotatable Bonds: 4

Polar Surface Area: 141.90

Molecular Species: BASE

HBA: 9

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 5

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.26

CX Basic pKa: 9.58

CX LogP: 0.62

CX LogD: -1.50

Aromatic Rings: 3

Heavy Atoms: 26

QED Weighted: 0.58

Np Likeness Score: -0.83

References

1. Rouse MB, Seefeld MA, Leber JD, McNulty KC, Sun L, Miller WH, Zhang S, Minthorn EA, Concha NO, Choudhry AE, Schaber MD, Heerding DA..  (2009)  Aminofurazans as potent inhibitors of AKT kinase.,  19  (5): [PMID:19179070] [10.1016/j.bmcl.2009.01.002]

Source

Source(1):

• Scientific Literature